Abstract
Avacincaptad pegol (IZERVAY (TM); formerly Zimura (R)) is a complement C5 inhibitor that is being developed by IVERIC Bio, an Astellas company, for th......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
